Cargando…
Particle toxicology and health - where are we?
BACKGROUND: Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution i...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480662/ https://www.ncbi.nlm.nih.gov/pubmed/31014371 http://dx.doi.org/10.1186/s12989-019-0302-8 |
_version_ | 1783413617028235264 |
---|---|
author | Riediker, Michael Zink, Daniele Kreyling, Wolfgang Oberdörster, Günter Elder, Alison Graham, Uschi Lynch, Iseult Duschl, Albert Ichihara, Gaku Ichihara, Sahoko Kobayashi, Takahiro Hisanaga, Naomi Umezawa, Masakazu Cheng, Tsun-Jen Handy, Richard Gulumian, Mary Tinkle, Sally Cassee, Flemming |
author_facet | Riediker, Michael Zink, Daniele Kreyling, Wolfgang Oberdörster, Günter Elder, Alison Graham, Uschi Lynch, Iseult Duschl, Albert Ichihara, Gaku Ichihara, Sahoko Kobayashi, Takahiro Hisanaga, Naomi Umezawa, Masakazu Cheng, Tsun-Jen Handy, Richard Gulumian, Mary Tinkle, Sally Cassee, Flemming |
author_sort | Riediker, Michael |
collection | PubMed |
description | BACKGROUND: Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution is one of the leading contributors to the global burden of disease, particles are also increasingly used for medical purposes. Over the past decades we have gained considerable experience in how particle properties and particle-bio interactions are linked to human health. This insight is useful for improved risk management in the case of unwanted health effects but also for developing novel medical therapies. The concepts that help us better understand particles’ and fibres’ risks include the fate of particles in the body; exposure, dosimetry and dose-metrics and the 5 Bs: bioavailability, biopersistence, bioprocessing, biomodification and bioclearance of (nano)particles. This includes the role of the biomolecule corona, immunity and systemic responses, non-specific effects in the lungs and other body parts, particle effects and the developing body, and the link from the natural environment to human health. The importance of these different concepts for the human health risk depends not only on the properties of the particles and fibres, but is also strongly influenced by production, use and disposal scenarios. CONCLUSIONS: Lessons learned from the past can prove helpful for the future of the field, notably for understanding novel particles and fibres and for defining appropriate risk management and governance approaches. |
format | Online Article Text |
id | pubmed-6480662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64806622019-05-01 Particle toxicology and health - where are we? Riediker, Michael Zink, Daniele Kreyling, Wolfgang Oberdörster, Günter Elder, Alison Graham, Uschi Lynch, Iseult Duschl, Albert Ichihara, Gaku Ichihara, Sahoko Kobayashi, Takahiro Hisanaga, Naomi Umezawa, Masakazu Cheng, Tsun-Jen Handy, Richard Gulumian, Mary Tinkle, Sally Cassee, Flemming Part Fibre Toxicol Review BACKGROUND: Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution is one of the leading contributors to the global burden of disease, particles are also increasingly used for medical purposes. Over the past decades we have gained considerable experience in how particle properties and particle-bio interactions are linked to human health. This insight is useful for improved risk management in the case of unwanted health effects but also for developing novel medical therapies. The concepts that help us better understand particles’ and fibres’ risks include the fate of particles in the body; exposure, dosimetry and dose-metrics and the 5 Bs: bioavailability, biopersistence, bioprocessing, biomodification and bioclearance of (nano)particles. This includes the role of the biomolecule corona, immunity and systemic responses, non-specific effects in the lungs and other body parts, particle effects and the developing body, and the link from the natural environment to human health. The importance of these different concepts for the human health risk depends not only on the properties of the particles and fibres, but is also strongly influenced by production, use and disposal scenarios. CONCLUSIONS: Lessons learned from the past can prove helpful for the future of the field, notably for understanding novel particles and fibres and for defining appropriate risk management and governance approaches. BioMed Central 2019-04-23 /pmc/articles/PMC6480662/ /pubmed/31014371 http://dx.doi.org/10.1186/s12989-019-0302-8 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Riediker, Michael Zink, Daniele Kreyling, Wolfgang Oberdörster, Günter Elder, Alison Graham, Uschi Lynch, Iseult Duschl, Albert Ichihara, Gaku Ichihara, Sahoko Kobayashi, Takahiro Hisanaga, Naomi Umezawa, Masakazu Cheng, Tsun-Jen Handy, Richard Gulumian, Mary Tinkle, Sally Cassee, Flemming Particle toxicology and health - where are we? |
title | Particle toxicology and health - where are we? |
title_full | Particle toxicology and health - where are we? |
title_fullStr | Particle toxicology and health - where are we? |
title_full_unstemmed | Particle toxicology and health - where are we? |
title_short | Particle toxicology and health - where are we? |
title_sort | particle toxicology and health - where are we? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480662/ https://www.ncbi.nlm.nih.gov/pubmed/31014371 http://dx.doi.org/10.1186/s12989-019-0302-8 |
work_keys_str_mv | AT riedikermichael particletoxicologyandhealthwherearewe AT zinkdaniele particletoxicologyandhealthwherearewe AT kreylingwolfgang particletoxicologyandhealthwherearewe AT oberdorstergunter particletoxicologyandhealthwherearewe AT elderalison particletoxicologyandhealthwherearewe AT grahamuschi particletoxicologyandhealthwherearewe AT lynchiseult particletoxicologyandhealthwherearewe AT duschlalbert particletoxicologyandhealthwherearewe AT ichiharagaku particletoxicologyandhealthwherearewe AT ichiharasahoko particletoxicologyandhealthwherearewe AT kobayashitakahiro particletoxicologyandhealthwherearewe AT hisanaganaomi particletoxicologyandhealthwherearewe AT umezawamasakazu particletoxicologyandhealthwherearewe AT chengtsunjen particletoxicologyandhealthwherearewe AT handyrichard particletoxicologyandhealthwherearewe AT gulumianmary particletoxicologyandhealthwherearewe AT tinklesally particletoxicologyandhealthwherearewe AT casseeflemming particletoxicologyandhealthwherearewe |